-
13:55
-14:00
Welcome
-
14:00
-14:20
*Efficacies of the second biologic agents in refractory ulcerative colitis patients in real-world practice
-
14:20
-14:40
*Real-world effectiveness and safety of JAK inhibitors in IBD
-
14:40
-15:00
*Real-world surgical intervention following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease
-
15:00
-15:20
IBD management under COVID-19 pandemic
-
15:20
-15:35
Discussion and Closing Remarks
-
15:35
-15:55
Coffee Break
AOCC Education Forum Real-world data in current IBD
